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Background: There are limited data on surgical outcomes in gynaecological oncology. We report on predictors of complications
in a multicentre prospective study.
Methods: Data on surgical procedures and resulting complications were contemporaneously recorded on consented patients
in 10 participating UK gynaecological cancer centres. Patients were sent follow-up letters to capture any further complications.
Post-operative (Post-op) complications were graded (I–V) in increasing severity using the Clavien-Dindo system. Grade I
complications were excluded from the analysis. Univariable and multivariable regression was used to identify predictors of
complications using all surgery for intra-operative (Intra-op) and only those with both hospital and patient-reported data for
Post-op complications.
Results: Prospective data were available on 2948 major operations undertaken between April 2010 and February 2012. Median
age was 62 years, with 35% obese and 20.4% ASA grade X3. Consultant gynaecological oncologists performed 74.3% of
operations. Intra-op complications were reported in 139 of 2948 and Grade II–V Post-op complications in 379 of 1462 surgeries.
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The predictors of risk were different for Intra-op and Post-op complications. For Intra-op complications, previous abdominal
surgery, metabolic/endocrine disorders (excluding diabetes), surgical complexity and final diagnosis were significant in univariable
and multivariable regression (Po0.05), with diabetes only in multivariable regression (P¼ 0.006). For Post-op complications, age,
comorbidity status, diabetes, surgical approach, duration of surgery, and final diagnosis were significant in both univariable and
multivariable regression (Po0.05).
Conclusions: This multicentre prospective audit benchmarks the considerable morbidity associated with gynaecological oncology
surgery. There are significant patient and surgical factors that influence this risk.
Treatment outcomes are increasingly used by commissioners and
consumers of health care to evaluate the performance of individual
clinicians and institutions. This has led to some specialities
developing clinician led national databases such as the National
Surgical Quality Improvement Programme (NSQIP) in the United
States (Khuri, 1998) and the national audits in cardiac surgery in
England (Bridgewater, 2010). The hallmark of such initiatives is
collection of comparable accurate data by clinical teams across
hospitals, which make the calculation of risk-adjusted morbidity
and mortality rates for surgical procedures possible. In gynaeco-
logical oncology, there is little such data available, with studies on
surgical outcomes limited to single centre reports from United
Kingdom (Das et al, 2006) and Australia (Kondalsamy
Chennakesavan et al, 2009) and a three centre US ovarian cancer
study (Aletti et al, 2007b)
In England, the outcome data for gynaecological oncology
procedures undertaken in the National Health Service (NHS) are
limited to a few procedures such as hysterectomy and includes both
benign and malignant disease. Surrogate markers of surgical
performance such as duration of hospital admission (‘length of stay’),
readmission and repeat surgery (‘return to theatre’) rates collected as
part of Hospital Episode Statistics (www.hesonline.nhs.uk) are used.
The latter is an administrative national data repository containing
details of all admissions, outpatient appointments and accident/
emergency attendances at NHS hospitals in England. It was initially
established to evaluate/monitor resource allocation but is now
increasingly being used to compare the quality of care provided by
NHS hospitals, with summary data accessible to the public on the web
(e.g., www.drfosterhealth.co.uk). However, studies comparing HES
outcome data with clinician databases have shown that it is prone to
error, omissions and inconsistencies (Westaby et al, 2007; Cockbain
et al, 2012). One of the reasons for this is that there is little clinical
input into data collection with coding officers capturing data from
clinical notes, which are not uniformly standardised or structured
across hospitals.
To address this lack of high quality outcome data in
gynaecological oncology, the United Kingdom Gynaecological
Oncology Surgical Outcomes and Complications (UKGOSOC)
study was undertaken to contemporaneously capture relevant data
from participating gynaecological oncology centres. Here, we
report on the type and incidence of intra- and post-operative
complications in gynaecological oncology surgery and significant
predictors of risk.
STUDY DESIGN AND METHODS
Certain aspects of the study design have been previously described
(Iyer et al, 2013). A web-based custom built database was designed
to capture data at various stages during the patient’s surgical
pathway, hosted on a secure server at the Trent Cancer Registry.
The website was accessible only through N3 (N3.nhs.uk), which is
a secure private network service used by NHS hospitals in England,
Wales and Scotland. Advice was sought from the Joint UCL/UCLH
Committees on the Ethics of Human Research in June 2008, which
confirmed that the study was similar to an audit and did not
require formal ethical review. However, because patients were sent
a follow-up letter (FUL) from the co-ordinating centre (CC) at
University College London (UCL), informed consent was obtained
(Supplementary File). Patients were given the option of providing
either identifiable or anonymised data as per their preference.
Data collection. Training in the use of the web-based programme
was provided by one of the CC team members either in person or
remotely via web conferencing. Each centre user had a unique
username and password. Clerical staff entered details of
consecutive surgical patients (who had given prior consent) listed
on the participating surgeon’s list. Clinical staff entered data on
surgery, Intra-op complications and the Post-op course (including
any complications) contemporaneously online from the theatre
and ward respectively. Once entered and saved, data could not be
deleted or changed unless the clinical teams contacted the CC.
All major surgical procedures performed on a gynaecological
oncology theatre list were included in the study. In addition to surgery
for malignancy, the procedures included surgery for benign conditions
where there was a high pre-operative suspicion of cancer, cases with a
complex surgical history which had been referred to the gynaecological
oncology team and risk-reducing surgery. Minor diagnostic procedures
and repeat surgery for complications were excluded.
Comorbidity. Pre-operative information on patients included age,
comorbidity, American Society of Anaesthesiologists (ASA) grade
(1–4) (Soliani, 1963), body mass index (BMI) and details of any
previous surgery. Comorbidity (yes/no) was captured under the
following categories: cardiac, coagulation/thrombosis, diabetes,
gastrointestinal, hypertension, integumentary/dermatology, infec-
tions, low albumin (o30 g l 1), metabolic/endocrine, neurological,
psychiatric, respiratory, smoking, vascular and other neoplasms.
Surgery. Surgical procedures were captured using the relevant
Office of the Population Censuses and Surveys (OPCS) Classifica-
tion of Interventions and Procedures version 4.5 and 4.6 codes.
Surgical complexity was classified using a modification of the
surgical scoring system (Supplementary Table 1) developed by
Aletti et al (2007a) for ovarian cancer. Each individual procedure
was given a score and the total score for the surgery was the sum of
the individual scores. For example, if adhesiolysis (score 1) and
ureterolysis (score 1) were performed along with a total abdominal
hysterectomy (TAH, score 1), the surgical complexity score was 3.
Surgeries were categorised into five groups of increasing complex-
ity based on the overall score (surgical complexity score 1 and 2:
Group 1; 3 and 4: Group 2; 5 and 6: Group 3; 7 and 8: Group 4;
48: Group 5). In addition to the procedure, the grade of operating
surgeon, duration of surgery, the surgical approach (open/
laparoscopic/vulval-vaginal) and estimated blood loss (EBL) were
also recorded.
Diagnosis. The diagnosis was recorded using the International
Statistical Classification of Diseases and Related Health Problems
codes (ICD-10) (WHO, 1990). For the analysis, the final
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histological diagnosis post-surgery was grouped into five cate-
gories: (1) ovarian which included primary ovarian/fallopian tube/
peritoneal, non-gynae primary and unknown primary cancers
(where the preoperative diagnosis had been suspected to be an
ovarian primary); (2) uterine which included primary endometrial
cancer, carcinosarcoma and sarcomas of the uterus; (3) cervix
(primary cervical cancer); (4) vulva which included primary vulval
and vaginal cancers; and (5) benign.
Complications. A surgical complication was defined as ‘an
undesirable and unintended result of an operation affecting
the patient that occurs as a direct result of the operation’ (Sokol
and Wilson, 2008). Post-op complications were defined as
those complications occurring post-operatively up to 8 weeks
after surgery. To capture Intra-op and Post-op complications, a
pre-determined list of complications was compiled following
literature review and several group discussions involving the
participating surgeons (Supplementary Table 2). Intra-op compli-
cations were recorded by the surgeons in theatre. Estimated blood
loss of 42.5 l was documented as Intra-op haemorrhage,
regardless of whether haemorrhage was specifically identified as
a complication by the operating surgeon. Completeness of Post-op
complications was ensured by including both hospital-reported
and patient-reported (via FULs) data as previously detailed (Iyer
et al, 2013). Post-op complications were graded I–V using the
Clavien and Dindo system based on the severity and intervention
required (Dindo et al, 2004) (Supplementary Table 3). Only Grade
II–V Post-op complications were included in the analysis. Grade 1
complications were excluded as they were by definition ‘any
deviation from the normal post-operative course not requiring any
pharmacological/surgical/radiological intervention’ and therefore
likely to be subject to individual variation and to have minimal
impact on the post-operative course (Iyer et al, 2013).
Data cleaning. The database was checked on a weekly basis by the
clinical research fellow (RI) at the CC and the centres were
contacted for any missing data or for clarification/correction of
erroneous data.
Statistical analysis. Statistical analysis was performed using
STATA version 12.1 (StataCorp 2012; StataCorp LP, College
Station, TX, USA). Descriptive statistics were used to characterise
the cohort. Surgery was used as the denominator for all the
analyses as there were 38 women who had undergone two separate
procedures as part of their treatment (repeat surgeries for
complications were excluded). In addition, it was possible that
age, comorbidity and ASA grade could change over time in an
individual woman. All eligible surgeries were included to calculate
the crude or unadjusted Intra-op complication rate (CR) and for
the Post-op CR analysis was limited to those with both hospital-
and patient-reported data. To assess how each potential predictor
affected the CR individually, univariable logistic regressions were
performed separately for all predictors. For Intra-op complications,
the independent variables included age, the presence of comorbid-
ities (yes/no), type of comorbidities, BMI (continuous variable and
categorical—underweight, normal, overweight, obese and morbidly
obese), ASA grade (1–4), previous abdominal surgery (yes/no),
grade of operating surgeon (consultant, sub-specialty trainee,
general obstetrics and gynaecology trainee), surgical approach
(laparotomy/laparoscopy), surgical complexity (1–5) and final
diagnosis (ovarian, uterine, cervix, vulva and benign). For Post-op
complications, two additional variables—duration of surgery (in
hours) and EBL (o500mls, 500–1000mls, 41000–2500mls,
42500mls) were included.
To create a risk prediction model for both the Intra-op and
Post-op CRs, useful predictors were identified in a multivariable
logistic regression model by running a stepwise regression with
backward elimination, with P (removal)¼ 0.05. Significant cate-
gorical predictors with more than two categories were retained
complete rather than dropping any insignificant categories.
Goodness of fit was assessed using the Hosmer–Lemeshow test
(with the data split into 10 groups based on estimated
probabilities). Since 38 women had repeated outcomes, the data
should formally be considered longitudinal (with very short
panels). Another possible source of correlated errors was through
clustering at each hospital. Hence, cluster robust standard errors
were used and additionally, a random effects logistic regression
model was fitted using the identified predictors to test the null
hypothesis that the possible clustering factors were not significant.
RESULTS
During the prospective UKGOSOC audit, undertaken between 1st
April 2010 and 29th February 2012, 10 centres submitted a total of
3026 operations. In all, 78 operations were excluded as they were
minor diagnostic procedures (54) and surgeries for complications
(24). The remaining 2948 operations involving 2910 women
(38 had two surgeries each) were included in the analysis. Patient-
reported complications were available for 1462 (68%) of the
surgeries and the CONSORT diagram for the latter has been
detailed previously (Iyer et al, 2013).
Patients. The baseline characteristics of the women are detailed in
Table 1 and the overall surgery details are described in Table 2.
Overall, 33.5% (989) of the surgeries were for ovarian, 27.8% (820)
for uterine, 7% (207) for cervical, 6% (176) for vulval cancer and
25.6% (756) for benign pathologies.
Surgery for individual diagnostic categories. For ovarian can-
cers, 93.4% (924 out of 989) of the operations were open
procedures and 6.6% (65 out of 989) were laparoscopic. In all,
8.2% (81) of the procedures required a bowel resection and 5.8%
(57) required upper abdominal debulking involving the diaphragm,
spleen, liver, etc.
For uterine cancers, 90% (738 out of 820) of the procedures
were total hysterectomies (±lymphadenectomy) of which 58.4%
(431 out of 738) were open procedures in which lymphadenectomy
had been performed in 38.5% (166 out of 431). In all, 41.6% (307
out of 738) of the hysterectomies were performed via the
laparoscopic approach in which lymphadenectomy was performed
in 26.8% (82 out of 307). The median BMI of women undergoing
the open vs laparoscopic hysterectomy was similar (30.1; IQR 25.7–
35.3 vs 31.3; IQR 26.1–36.2, respectively).
For cervical cancers, 26.6% (55 out of 207) of the procedures
were open radical hysterectomies in which lymphadenectomy had
been performed in 76.6% (42). In all, 24.2% (50 out of 207) were
laparoscopic radical hysterectomies which included lymphadenect-
omy in 94% (47). The median BMI for the two approaches was
similar, 26.3 (IQR 23.2–31.6) for open and 25 for laparoscopic
(IQR 22.4–30.7).
For vulval cancer, vulvectomy was the commonest procedure
(95 out of 176, 54%), followed by vulvectomy with inguinofemoral
lymphadenectomy (46 out of 176, 26.1%).
For benign pathology, total abdominal hysterectomy (TAH) with
bilateral salpingo-oophorectomy (BSO)þ omentectomy/lymphade-
nectomy/appendicectomy (318 out of 756, 42.1%) was the commonest
procedure followed by simple TAH with BSO (178 out of 756, 23.5%).
Intra-operative complications. In total, 139 of 2948 surgeries had
an Intra-op complication giving an overall Intra-op CR of 4.7%
(95% CI 4.0–5.6). This included 143 individual Intra-op complica-
tions (i.e., four surgeries had two complications each) (Table 3).
Intra-op haemorrhage (28.7%; 41 out of 143) followed by bladder
(15.4%; 22 out of 143) and small bowel (15.4%; 22 out of 143)
Predictors of complications in gynaecological oncological surgery BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2014.630 3
injury were the most frequently occurring Intra-op complications.
In the 2192 operations with a cancer diagnosis, 118 had an Intra-
op complication resulting in an Intra-op CR for cancer surgery of
5.4% (95% CI 4.5–6.4) and this included 121 individual Intra-op
complications.
The highest Intra-op CR was for ovarian cancer surgery (78 out
of 989; 7.9%, 95% CI 6.4–9.7). Two out of the three exenterations
had an Intra-op complication (66.8%). The Intra-op CR was 19.8%
(16 out of 81) for procedures with bowel resection and 14% (8 out
of 57) for procedures involving upper abdominal surgery.
Cervical cancer surgery had the second highest Intra-op CR (10
out of 207, 4.8%; 95% CI 2.6–8.7). The Intra-op CR for the subset
of open radical hysterectomies was 5.5% (3 out of 55) and was
almost double (10%, 5 out of 50) for laparoscopic radical
hysterectomies. Emergency laparotomy was required for only one
(2%; 1 out of 50) of the laparoscopic radical hysterectomies.
For uterine cancer surgery, the overall Intra-op CR was 3.4% (28
out of 820, 95% CI 2.4–4.9). Where hysterectomy was undertaken,
the Intra-op CR was 2.6% (11 out of 431) for the open approach
and 3.6% (11 out of 307) for the laparoscopic approach. The Intra-
op CR for the subgroup of hysterectomies with lymphadenectomy
was 1.8% (3 out of 166) for open and 7.3% (6 out of 82) for
laparoscopic surgery. The unscheduled laparotomy rate for the
laparoscopic approach was 1.6% (5 out of 307).
Intra-op haemorrhage was the most common complication for
ovarian, uterine and cervical cancer surgery (Table 3).
Table 1. Baseline characteristics
Baseline characteristics (n¼2948)
Age (in years, median, IQR) 62 (50–71)
BMI
BMI (median, IQR) 27.4 (23.8–32.4)
BMI category n (%)
Underweight (o18.5) 41 (1.4)
Normal (18.5–24.9) 897 (30.4)
Overweight (25–29.9) 895 (30.4)
Obese (30–39.9) 805 (27.3)
Morbidly obese (X40) 236 (8)
Missing 74 (2.5)
ASA grade
1 and 2 2341 (79.4)
X3 600 (20.4)
Missing 7 (0.2)
Comorbidity
0 1105 (37.5)
1–3 1716 (58.2)
43 127 (4.3%)
Type of comorbidity
Hypertension 973 (33)
Cardiac 308 (10)
Diabetes 298 (10)
Respiratory 287 (10)
Musculoskeletal 261 (9)
Neurology/psychiatric 208 (7)
Other neoplasms 148 (5)
Coagulation/thrombosis 116 (4)
Gastrointestinal 104 (4)
Smoking 95 (3)
Vascular 86 (3)
Genitourinary 52 (2)
Autoimmune 37 (1)
Integumentary/Dermatology 30 (1)
Infections 13 (0.4)
Low albumin 11 (0.4)
Previous abdominal surgery 1025 (34.7)
Abbreviations: ASA¼American Society of Anaesthesiologists; BMI¼body mass index;
IQR¼ interquartile range.
Table 2. Surgery details
Grade of operating surgeon n (%)
Consultant 2191 (74.3)
Sub-specialty trainee 573 (19.4)
General Obstetrics and Gynaecology Trainee 108 (3.7)
Missing 76 (2.6)
Diagnosis n (%)
Ovariana 989 (33.5)
Uterineb 820 (27.8)
Cervical 207 (7.0)
Vulvalc 176 (6.0)
Benign 756 (25.7)
Surgical approach n (%)
Open 2001 (67.9)
Laparoscopic elective proceed to laparotomy 68 (2.3)
Laparoscopic emergency proceed to laparotomy 11 (0.3)
Laparoscopicd 670 (22.7)
Vulval/vaginal procedures 198 (6.7)
Duration of surgery (minutes) Median, IQR
Open procedures 120 (90–167)
Laparoscopic procedures 120 (85–170)
Vulval/vaginal procedures 87 (50–148)
Surgical complexity n (%)
Group 1 (complexity score 1 and 2) 1398 (47)
Group 2 (complexity score 3 and 4) 982 (33)
Group 3 (Complexity score 5 and 6) 430 (15)
Group 4 (complexity score 7 and 8) 93 (3)
Group 5 (complexity score 48) 45 (2)
Surgical procedures n (%)
TAH±BSOþomentectomy /appendicectomy/
lymphadenectomy/peritonectomy
1202 (40.8)
TAH±BSO/USO 448 (15.2)
Radical hysterectomy±BSO±lymphadenectomy 106 (3.6)
TAH/BSO/omentectomyþbowel resection 94 (3.2)
TAHþBSOþomentectomyþ upper abdominal
surgery
58 (2.0)
Exenterations±conduits 16 (0.5)
Open lymphadenectomy 14 (0.5)
Exploratory/abandoned procedure 29 (1.0)
Other open procedures 105 (3.6)
TLH/LAVHþBSO 306 (10.4)
TLH or LAVH±omental biopsyþ lymphadenectomy 262 (8.9)
Laparoscopic radical hysterectomy
±lymphadenectomy
65 (2.2)
Laparoscopic lymphadenectomy 30 (1.0)
Other laparoscopic procedures 18 (0.6)
Vulvectomy (radical/simple) 113 (3.8)
Vulvectomyþ Inguinofemoral lymphadenectomy 46 (1.6)
Inguinofemoral lymphadenectomy 18 (0.6)
Vaginectomy 12 (0.4)
Other vulval/vaginal procedures 6 (0.2)
Length of stay Days, median
(IQR)
Open procedures 4 (3–6)
Laparoscopic 2 (1-2)
Vulval/vaginal procedures 4 (2–7)
Abbreviations: BSO¼bilateral salpingo-oophorectomy; LAVH¼ laparoscopic assisted
vaginal hysterectomy; TAH¼ total abdominal hysterectomy; TLH¼ total laparoscopic
hysterectomy; USO¼ unilateral salpingo-oophorectomy.
aIncludes primary ovarian, fallopian tube, primary peritoneal, synchronous, non-gynae
primary cancers.
bIncludes primary endometrial cancer, carcinosarcoma and sarcoma of the uterus.
cIncludes primary vulval and vaginal cancers.
dIncludes total laparoscopic and laparoscopic assisted vaginal procedures.
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There were only two surgeries with an Intra-op complication for
vulval cancer (2 out of 176, 1.1%; 95% CI 3.1–4.1) and both were
bladder injuries. The Intra-op CR (21 out of 756, 2.8%; 95% CI 1.8–
4.2) was lower for benign conditions when compared with ovarian,
uterine and cervix cancer surgery. Bladder and large bowel injuries
were the most commonly occurring complications (4 out of 756, 0.5%).
The Intra-op CR increased with increasing surgical complexity
with rates of 2.9% (41 out of 1398) for a surgical score ofo3, 4.4%
(43 out of 982) for a score of 3–4, 7.9% (34 out of 430) for a score
of 5–6, 12.9% (12 out of 93) for a score of 7–8 and 20% (9 out of
45) for a score of 48. Overall, the highest Intra-op CR was seen
for procedures with bowel resection (18 out of 94, 19.1%) and
exenterations (3 out of 16, 18.8%) followed by debulking surgery
requiring upper abdominal resection (8 out of 58, 13.8%).
Post-operative complications. Both hospital and patient reported
data on Post-op complications were available for 1462 surgeries.
There were 200 hospital-reported and 252 patient-reported Grade
II–V complications in 379 surgeries resulting in an overall Post-op
CR of 25.9% (95% CI 23.7–28.2) as previously reported (Iyer et al,
2013). Out of the total 452 Grade II–V complications, wound
(140 out of 452, 30.9%) and other infections (126 out of 452, 27.8%)
were the most common (Table 4). In the 1067 operations leading to a
cancer diagnosis, 289 had a Post-op complication resulting in a Post-
op CR for cancer surgery of 27.1% (95% CI 24.5–29.8).
Surgery for vulval cancer had the highest Post-op CR (33 out of 79,
41.8% 95% CI 31.5–52.8). Wound breakdown/infection (26 out of 79,
32.9%) was the most common complication. In over one in three
procedures with inguinofemoral lymphadenectomy, the main com-
plication was lymphocysts/lymphoedema (15 out of 42, 35.7%).
Cervical cancer surgery had a similar Post-op CR (32 out of
80, 40%; 95% CI 29.9–50.9) to vulval cancer surgery with similar
rates for open (11 out of 27, 40.7%) vs laparoscopic radical
hysterectomy±lymphadenectomy (8 out of 20, 40%). Infections
(excluding wound) were the most common complication
(7 out of 80, 8.8%). When compared with vulval cancer surgery,
the incidence of lymphocysts/lymphoedema was lower at 12.7%
(7 out of 55 procedures with lymphadenectomy).
Ovarian cancer surgery had a significantly lower Post-op CR
(128 out of 481, 26.6%, 95% CI 22.9–30.7) when compared with
vulval and cervical cancer surgery. Exenterations (one out of two;
50%), procedures including upper abdominal surgery (11 out of
26, 42.3%) and bowel resection (11 out of 35, 31.4%) had the
highest rates. Infections (excluding wound) remained the most
common (8.5%; 41 out of 481) complication.
The Post-op CR for uterine cancer surgery was 22.5% (96 out
of 427, 22.5%; 95% CI 18.8–26.7). The Post-op CR for
hysterectomies±lymphadenectomy was 26.8% (63 out of 235)
for the open and 16.2% (25 out of 154) for the laparoscopic
approach. For the subset of hysterectomies with lymphadenect-
omy, the Post-op CR was 37.9% (36 out of 95) for the open and
19.6% (10 out of 51) for the laparoscopic approach. The incidence
of lymphocysts/lymphoedema was 7.1% (11 out of 156) for
procedures with lymphadenectomy, a lower rate than that for
cervical and vulval cancers.
For benign pathology, the Post-op CR was 22.8% (90 out of 395;
95% CI 18.9–27.2). TAH with BSO had the highest Post-op CR
(29 out of 96, 30.2%) followed by Total Laparoscopic Hysterectomy
(±BSO) (10 out of 38, 26.3%). Wound breakdown (38 out of 395,
9.6%) and infections (excluding wound) (33 out of 395, 8.4%) were
the most common type of complications (Table 4).
Grade of complications. In total, 402 (88.9%) out of the 452
complications in this cohort of 1462 surgeries were Grade II and 50
(11.1%) were Grade III or worse (8 Grade IIIa, 30 Grade IIIb, 10
Grade IVa and 2 Grade V) (Supplementary Table 4).
Table 3. Intra-operative complications
Intra-operative complications (no. of surgery¼2948)
Primary cancer site
Complication category Total no. (% with complication) Ovarya Uterineb Cervix Vulvac Benign
Intra-operative haemorrhage 41 (28.7) 27 8 3 3
Bladder injury 22 (15.4) 11 3 2 2 4
GI tract injury—small bowel 22 (15.4) 16 4 2
GI tract injury—large bowel 11 (7.7) 4 2 1 4
Vascular injury 13 (9.1) 7 2 1 3
Vaginal tear 7 (4.9) 5 2
Cardiac 6 (4.2) 2 1 3
Diaphragmatic injury 5 (3.5) 5
Ureteric injury 5 (3.5) 1 2 1 1
Splenic injury 3 (2.1) 3
Gall bladder injury 1 (0.7) 1
Liver laceration 1 (0.7) 1
Nerve injury 1 (0.7 1
Respiratory 1 (0.7) 1
Uterine perforation 1 (0.7) 1
Anaphylaxis 1 (0.7) 1
Other 2 (1.4) 1 1
Total no. of intra-op complications (% of total surgery) 143 (4.9%) 79 (7.9%) 30 (3.4%) 10 (4.8%) 2 (1.1%) 22 (2.8%)
Total no. of surgeries 2948 989 820 207 176 756
aIncludes primary ovarian, fallopian tube, primary peritoneal, synchronous, non-gynae primary cancers.
bIncludes primary endometrial cancer, carcinosarcoma and sarcoma of the uterus.
cIncludes primary vulval and vaginal cancers.
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There were 48 re-admissions (48 out of 1462, 3.6%), 34 returns
to theatre (30 Grade IIIb and 4 Grade IVa; 2.3%) and 10 (2.2%)
unscheduled admissions to intensive care. There were two (0.14%)
peri-operative deaths reported in this cohort, one due to cardiac
failure and the other secondary to bowel perforation.
Predictors of complications
Intra-op CR. In univariable analysis, the significant predictors of
Intra-op complications were previous abdominal surgery,
metabolic/endocrine conditions excluding diabetes (patient
factors), surgical complexity and final diagnosis (Table 5,
Supplementary Table 5). In multivariable regression, all four
factors continued to be significant with previous abdominal
surgery (OR¼ 1.6), increasing surgical complexity (Po0.0005)
and ovarian cancer diagnosis (Po0.0005) increasing risk along
with diabetes (OR¼ 2) and the presence of metabolic/endocrine
disorders (excluding diabetes) (OR¼ 0.35) associated with
decreased risk of Intra-op complication (Table 5).
Post-op-CR. In univariable regression, the significant patient
factors associated with increased risk of Post-op complications
were diabetes, the presence of any comorbidity, previous
abdominal surgery and increasing ASA grade, age and BMI
(Table 6, Supplementary Table 6). Among the Intra-op factors,
surgical complexity, surgery duration and EBL increased risk
whereas laparoscopic compared with open approach reduced
the likelihood of a Post-op complication. As with Intra-
op complications, final diagnosis was a significant predictor. In
multivariate regression, the only patient factors that increased risk
were the presence of comorbidity (OR¼ 1.3) and diabetes
(OR¼ 1.6). Significant Intra-op variables were laparoscopic
approach that was associated with decreased risk of Post-op
complications (OR¼ 0.65) and duration of surgery in hours that
increased risk (OR¼ 1.3). Unlike for Intra-op complications,
increased risk was associated with a diagnosis of vulval/vaginal
(OR¼ 2.4) and cervical cancer (OR¼ 1.7).
DISCUSSION
This prospective multicentre UK study is the largest published
study that we are aware of which reports on the morbidity
associated with surgery undertaken in gynaecological oncology
centres. Whilst the overall Intra-op CR was 4.7%, it was 5.4% when
limited to confirmed malignancies. Previous abdominal surgery,
diabetes, surgical complexity and final diagnosis were significant
predictors of increased risk. The Post-op CR was similar for overall
(26%) and for confirmed malignancies (27%). The only common
predictors of both Intra-op and Post-op complications were
diabetes and final diagnosis. Other significant associations with
Post-op complications were age, the presence of comorbidity,
Table 4. Hospital and patient-reported post-operative complications
Grade II–V hospital- and patient-reported post-operative complications (no. of surgery¼1462)
Primary cancer site
Complication category Total no. (% with complication) Ovarya Uterineb Cervix Vulvac Benign
Wound breakdown 140 (30.1) 37 35 4 26 38
Infection 126 (27.8) 41 30 17 5 33
Lymphocyst/lymphoedema 39 (8.6) 6 11 7 15
Bladder 17 (3.8) 2 7 2 6
Abscess/haematoma 14 (3.1) 6 2 2 4
Ileus 16 (3.5) 11 3 2
Bowel obstruction 7 (1.5) 5 1 1
Bowel perforation 2 (0.4) 1 1
Bowel—other 11 (2.4) 5 1 1 4
Primary haemorrhage 5 (1.1) 2 2 1
Secondary haemorrhage 10 (2.2) 2 3 1 4
Fistula 7 (1.5) 4 1 1 1
Anastomotic leak 2 (0.4) 2
Cardiac 7 (1.5) 4 2 1
Pulmonary embolism 5 (1.1) 3 2
Deep vein thrombosis 5 (1.1) 2 1 1 1
Respiratory 6 (1.3) 3 2 1
Neurological 4 (0.9) 1 3
Psychiatric 2 (0.4) 1 1
Hernia 4 (0.9) 3 1
Ureteric obstruction 1 (0.2) 1
Other 22 (4.9) 8 5 2 1 6
Total no. of post-operative complications
(% of total surgery)
452
(30.9)
148
(30.7)
112
(26.2)
38
(47.5)
47
(59.5)
107
(27.1)
Total no. of surgeries 1462 481 427 80 79 395
aIncludes primary ovarian, fallopian tube, primary peritoneal, synchronous, non-gynae primary cancers.
bIncludes primary endometrial cancer, carcinosarcoma and sarcoma of the uterus.
cIncludes primary vulval and vaginal cancers.
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surgical approach and duration of surgery. Gynaecological
oncology surgery is associated with considerable morbidity and
our study provides much needed estimates of complication risk
associated with procedures for specific cancers to counsel patients
and benchmark surgical performance.
Strengths of UKGOSOC include prospective data collection
using standard forms, large sample size and multicentre design
with 10 participating gynaecological cancer centres. Data capture
from both clinicians and patients ensured completeness of Post-op
complications. An online database, accessible to the clinical team
whether they were in theatre, wards or outpatient departments
facilitated capture of surgical data and complication events
contemporaneously. Validity of the data was ensured by weekly
review by an independent clinician at the CC, who contacted the
teams on a regular basis to retrieve missing data and ‘clean’
erroneous entries. While clinician-led databases collect more
accurate and complete information compared with administrative
databases like HES (RCOG, 2012), this was a very resource
intensive process. The heavy reliance of UKGOSOC on the clinical
teams was a limitation. Most centres, especially those relying on
junior trainees on four to six monthly rotations, struggled with
prospective data entry.
As this was a prospective study rather than an audit, patient
consent was required. In keeping with majority of clinical studies,
we are unable to provide an accurate number of women who were
approached. Therefore, it is likely that all consecutive patients on
operating lists have not been included. In 10% of surgeries, patients
had Metabolic/Endocrine disorders other than diabetes. This
mainly included hypercholesterolaemia and thyroid dysfunction
and was a predictor of reduced intra-operative CR. We are unable
to explain this and as previous studies have not looked at this
separately, there is no data for comparison. Some pre-operative
biochemical markers such as serum albumin and liver enzymes
that have been reported to be predictors of surgical complications
(Khuri, 1998; Copeland, 2002; Aletti et al, 2007b; Kondalsamy
Chennakesavan et al, 2009) could not be included in our study as
they are not routinely assayed in all patient undergoing
gynaecological oncology surgery in United Kingdom.
Our overall Intra-op CR of 4.7% was lower than the 8% reported
from a tertiary gynaecological oncology centre in Australia
(Kondalsamy Chennakesavan et al, 2009), which we feel was
probably influenced by the small sample size of 381 women in their
study compared with nearly 3000 in ours (Kondalsamy
Chennakesavan et al, 2009). No other comparable figures were
available in the published literature. Rates for gynaecological
malignancy alone were lower than Intra-op CRs in women
undergoing pelvic surgery for rectal cancer surgery (12%) (van
der Pas et al, 2013). The lower incidence of Intra-op complications
was paralleled by the lower (1.6%) laparoscopic to emergency
laparotomy conversion rates compared with the Australian
study (2.4%) and the rectal cancer surgery multicentre trial
(16%) (van der Pas et al, 2013). Lower CRs in surgeries for
gynaecological compared with colorectal cancer are likely to be
related to the lower rates of bowel resection and possible
Table 5. Significant predictors of intra-operative complications in univariable and multivariable regression
Variable Odds ratio 95% Confidence interval Standard error P-value
Univariable analysis of risk factors for intra-operative complications as the outcome
Previous abdominal surgery 1.74 1.239-2.455 0.304 0.001
Metabolic/endocrine (excluding diabetes) 0.383 0.168–0.876 0.162 0.023
Surgical complexity group
1 1
2 1.516 0.980–2.344 0.337 0.061
3 2.841 1.779–4.539 0.679 0.000
4 4.903 2.481–9.690 1.704 0.000
5 8.274 3.741–18.301 3.351 0.000
Joint significance for all the categories in surgical complexity 0.000
Final diagnosis
Ovary 1
Uterine 0.413 0.265–0.643 0.093 0.000
Benign 0.334 0.204–0.546 0.084 0.000
Vulva 0.134 0.033–0.551 0.097 0.005
Cervix 0.593 0.302–1.166 0.205 0.130
Joint significance for all the categories in final diagnosis 0.000
Multivariable logistic regression model for intra-operative complication as the outcome
Diabetes 2.015 1.223–3.324 0.514 0.006
Metabolic/endocrine disorders (excluding diabetes) 0.351 0.152–0.809 0.150 0.014
Previous abdominal surgery 1.561 1.099–2.219 0.280 0.013
Surgical complexity group
1 1
2 1.302 0.834–2.033 0.296 0.246
3 2.311 1.396–3.826 0.594 0.001
4 3.397 1.660–6.951 1.241 0.001
5 5.399 2.335–12.48 2.309 0.000
Final diagnosis
Ovary 1
Uterine 0.555 0.348–0.887 0.133 0.014
Cervix 0.599 0.296–1.212 0.215 0.154
Vulva 0.193 0.046–0.805 0.141 0.024
Benign 0.468 0.278–0.787 0.124 0.004
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anastomosis and resultant lower incidence of anastomotic leaks,
peritonitis or other bowel complications. In UKGOSOC, only 4.2%
(91 out of 2192) of the cancer surgeries required a bowel resection.
Previous abdominal surgery was a significant predictor of Intra-
op complications probably due to intra-abdominal adhesions
following the previous surgery. This is in keeping with results of a
prospective multicentre Finnish study (FINHYST) of over 5000
hysterectomies for benign indications (Brummer et al, 2011),
which found that prior laparotomy (OR¼ 1.1) but not caesarean
section or laparoscopy increased the risk of major complications.
In the latter study, adhesiolysis during surgery was the strongest
single risk factor (OR¼ 2.4). In bowel surgery, previous three or
Table 6. Significant predictors of post-operative complications in univariable and multivariable regression
Variable Odds ratio 95% Confidence interval Standard error P-value
Univariable analysis for post-operative complications as the outcome
Age 1.014 1.002–1.026 0.006 0.027
Comorbidity status (yes/no) 1.477 1.049–2.077 0.257 0.025
Diabetes 1.916 1.233–2.977 0.431 0.004
Previous abdominal surgery 1.465 1.068–2.011 0.237 0.018
Body mass index (continuous variable) 1.023 1.001–1.045 0.011 0.039
Body mass index (categorical variable)
Underweight (o19.9) 1
Normal (19.9–24.9) 0.709 0.156–3.231 0.549 0.657
Overweight (25–29.9) 0.888 0.196–4.017 0.684 0.877
Obese (30–39.9) 1.359 0.302–6.120 1.044 0.689
Morbidly obese (440) 0.948 0.193–4.652 0.769 0.947
Joint significance for all the categories in BMI 0.037
ASA grade (1–3)
ASA grade 1 1
ASA grade 2 1.623 1.0422–2.527 0.367 0.032
ASA grade X3 2.178 1.315–3.608 0.561 0.002
Joint significance for all the categories in ASA grade 0.008
Duration of surgery 1.496 1.324–1.690 0.093 0.000
Approach for surgery
Open 1
Laparoscopic 0.506 0.326–0.787 0.114 0.002
Surgical complexity group
1 1
2 1.719 1.196–2.469 0.318 0.003
3 1.896 1.198–3.003 0.445 0.006
4 2.652 1.218–5.774 1.053 0.014
5 6.562 2.454–17.543 3.292 0.000
Joint significance for all the categories in surgical complexity 0.000
Estimated blood loss (EBL)
o500 mls 1
500–1000mls 2.554 1.737–3.756 0.502 0.000
41000–2500mls 2.443 1.381–4.319 0.710 0.002
42500mls 0.797 0.102–6.226 0.710 0.829
Joint significance for all the categories in EBL 0.000
Final diagnosis
Ovary 1
Uterine 0.609 0.407–0.914 0.126 0.016
Cervix 1.623 0.908–2.901 0.481 0.102
Vulva 2.024 1.158–3.535 0.576 0.013
Benign 0.41 0.258–0.652 0.097 0.000
Joint significance for all the categories in final diagnosis 0.000
Multivariable logistic regression model for post-operative complication as the outcome
Comorbidity status (Yes/No) 1.338 1.012–1.769 0.191 0.041
Diabetes 1.642 1.113–2.421 0.325 0.012
Age 0.989 0.979–1.000 0.005 0.052
Laparoscopic approach 0.653 0.469–0.909 0.110 0.012
Duration of surgery 1.285 1.149–1.439 0.074 0.000
Final diagnosis
Ovary 1
Uterine 0.998 0.716–1.392 0.169 0.992
Cervix 1.664 0.958–2.891 0.469 0.071
Vulva 2.398 1.438–3.999 0.626 0.001
Benign 1.046 0.738–1.481 0.186 0.802
Abbreviations: ASA¼American Society of Anaesthesiologists; BMI¼body mass index.
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more laparotomies have been found to increase risk of enterotomy
by tenfold (OR¼ 10.4) (Van Der Krabben et al, 2000). The other
comorbidity that significantly increased Intra-op complication risk
was diabetes (OR¼ 2). While several studies have demonstrated
the association of diabetes with increased Post-op morbidity
(Pull et al, 2012; Gimenes et al, 2013; Fischer et al, 2014) this is the
first study to demonstrate its effect specifically on Intra-op
complications.
Intra-op CRs increased with surgical complexity with the
highest rates for those procedures with an overall surgical
complexity score of 48. In Aletti’s study on ovarian cancer
surgery as well as in the Australian study (Kondalsamy
Chennakesavan et al, 2009), surgical complexity was found to be
a significant predictor of overall morbidity. To capture complexity
accurately in UKGOSOC, the surgical complexity scoring system
for ovarian cancer developed by Aletti et al (2007a,b) was modified
to include procedures for all gynaecological cancers and stratified
into five rather than the three originally described (low,
intermediate and high) groups as preliminary analysis had
demonstrated it to be a key predictor. Although a higher
proportion of procedures were of low complexity in UKGOSOC,
we feel that direct comparisons with the Australian study are
difficult to make as surgical complexity was defined differently in
the two studies. Surgery for ovarian cancer had the highest crude
Intra-op CR at 8% which was double of that seen for the
other gynaecological cancers. This is mainly influenced by the
complexity of ovarian cancer surgery when compared with that for
the others (11% of ovarian cancer surgery had an overall
complexity score of 45 when compared with 1–3% of the
procedures for the other gynaecological malignancies).
When compared with Intra-op-CR, the Post-op-CR was much
higher with approximately one in four surgeries having a Post-op
complication. However, most of the complications were Grade II,
which required medical therapy only as previously reported (Iyer
et al, 2013). Vulval cancer (OR¼ 2.4) when compared with other
cancers and benign diagnosis posed the highest risk of developing a
Post-op complication. Vulval cancer surgery also had the highest
crude Post-op-CR (41.8%) with wound infection/breakdown the
commonest complication (32.9%) followed by lymphocysts/lym-
phoedema (18.9%). These rates were comparable to that reported in
a recent review of complications of vulval cancer surgery where
wound infection rates ranged from 17% to 39% and lymphoedema
rates between 14% and 48% (Wills and Obermair, 2013). The
incidence of intra-operative ureteric and bladder injury and post-
operative bladder complications was highest for cervical cancer
surgery when compared with other gynaecological cancers. How-
ever, this difference was not statistically significant (Supplementary
Tables 7 and 8). This is likely to be related to the higher proportion
of radical hysterectomies undertaken for cervical cancer. Overall,
however, the rates are lower than those reported elsewhere, as in the
United Kingdom, majority of radical hysterectomies are Type II
rather than Type III as they are undertaken in patients with smaller
tumours (Mota et al, 2008). Tumours of44 cm are more likely to be
treated with chemo-radiation.
As previously reported, in studies comparing open vs laparo-
scopic approaches for endometrial and cervical cancer surgery
(Walker et al, 2009; Park et al, 2013), the latter reduced the
likelihood of a Post-op complication in our series too. This is
probably one of the main drivers for the increasing use of
laparoscopic surgery in gynaecological oncology. Surgical complex-
ity however was not a significant predictor of Post-op unlike Intra-
op complications. Instead, duration of surgery (OR¼ 1.3) was
significant. This has also been noted to increase the risk of Post-
operative infections following total knee arthroplasty (Peersman
et al, 2006).
In addition to being a significant predictor of Intra-op
complications, diabetes (OR¼ 1.6) was also found to be significant
in predicting Post-op complications. In the Australian study, while
diabetes was significant in univariable analysis, it was not found to
be so in multivariable analysis (Kondalsamy Chennakesavan et al,
2009). However, studies in other specialties such as plastic surgery
(breast reconstruction surgery) and orthopaedic surgery have
shown diabetes to be a significant predictor of surgical complica-
tions, particularly wound infections (Pull et al, 2012; Liang et al,
2013; Fischer et al, 2014). Diabetes has also been found to increase
the risk of Post-op complications following coronary artery bypass
surgery (Gimenes et al, 2013). Our data indicate that the presence
of any comorbidity (OR¼ 1.3) predicted Post-op complications
on multivariable analysis. Performance status as measured by ASA
grade was significant only on univariable analysis. This is in
contrast to the Australian study and Aletti’s study where ASA
grade was a significant independent predictor for overall morbidity
(Aletti et al, 2007a; Kondalsamy Chennakesavan et al, 2009).
The 18-month prospective study was driven by the determina-
tion and desire of those involved to obtain robust data. National
data collection in this manner without dedicated administrative
support would not be feasible. For such data to be collected on a
national scale, one of the options would be to incorporate some of
the key audit fields into existing data sources coupled with routine
central follow-up of patients using validated questionnaires.
Despite the logistical issues, internal auditing using the system of
clinician led data capture adopted in this study might still be
preferable and acceptable to clinicians rather than external
regulations that might be imposed in the foreseeable future
(Hacker, 2011).
CONCLUSIONS
This the first large multicentre prospective study to investigate the
morbidity associated with gynaecological oncology surgery.
A set of robust complications data has been generated, which
can be utilised for future benchmarking surgical practice. There are
significant patient and surgical factors that influence risk, raising
the need for risk-adjusted rates to compare outcomes.
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